Ken Griffin Outset Medical, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$1.94 - $4.61 $123,578 - $293,657	63,700 Added 376.92%	80,600 $310,000
Q1 2024 May 15, 2024	BUY	$1.99 - $5.64 $12,139 - $34,404	6,100 Added 56.48%	16,900 $37,000
Q4 2023 Feb 14, 2024	SELL	$3.07 - $10.25 $7,061 - $23,575	-2,300 Reduced 17.56%	10,800 $58,000
Q3 2023 Nov 14, 2023	BUY	$10.52 - $20.68 $31,560 - $62,040	3,000 Added 29.7%	13,100 $142,000
Q2 2023 Aug 14, 2023	BUY	$17.18 - $23.76 $87,618 - $121,176	5,100 Added 102.0%	10,100 $220,000
Q1 2023 May 15, 2023	BUY	$18.25 - $30.26 $40,150 - $66,572	2,200 Added 78.57%	5,000 $92,000
Q4 2022 Feb 14, 2023	BUY	$12.36 - $26.41 $34,608 - $73,948	2,800 New	2,800 $72,000

121

37.6M

65.1K

91.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $29.8M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.